{"id":22803,"date":"2017-10-10T09:54:36","date_gmt":"2017-10-10T09:54:36","guid":{"rendered":"https:\/\/corporate.webfactory.ferring.tech\/?p=22803"},"modified":"2021-05-10T18:06:26","modified_gmt":"2021-05-10T17:06:26","slug":"ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device","status":"publish","type":"post","link":"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/","title":{"rendered":"Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device"},"content":{"rendered":"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h2 style=\"color: #0088ce\">Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device<\/h2>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<ul>\n<li>Ferring enters agreement with Antares Pharma Inc. for worldwide rights to ZomaJet\u2122 needle-free injector device<\/li>\n<\/ul>\n<ul>\n<li>ZomaJet is used to deliver Ferring\u2019s Zomacton<strong><sup>\u00ae<\/sup><\/strong>\u00a0(somatropin), indicated to treat Growth Hormone Deficiency in children and Turner Syndrome in girls<\/li>\n<\/ul>\n<ul>\n<li>ZomaJet helps increase adherence to treatment through its needle-free feature and the ability to self-administerm <sup><a href=\"#note1\">1<\/a>,<a href=\"#note2\">2<\/a>,<a href=\"#note3\">3<\/a><\/sup><\/li>\n<\/ul>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 style=\"color: #0088ce\">Saint-Prex, Switzerland \u2013 10 October 2017 \u2013<\/h3>\n<p>Ferring Pharmaceuticals announced today that it has entered into a definitive agreement with Antares Pharma, Inc. to acquire the worldwide rights for the ZomaJet\u2122 needle-free auto injector device.<\/p>\n<p>This transaction is subject to customary closing conditions. Antares will continue to manufacture and supply the ZomaJet device until completion of existing supply arrangements, expected by the end of 2018.<\/p>\n<p>ZomaJet is used to deliver Ferring\u2019s Zomacton<strong><sup>\u00ae<\/sup><\/strong>\u00a0(somatropin), a treatment indicated for the treatment of Growth Hormone Deficiency (GHD) in children and Turner Syndrome in girls.<\/p>\n<p>\u201cThrough the acquisition of ZomaJet, we are consolidating our Zomacton franchise and commitment to improving quality of life and care for children with growth disorders,\u201d said Michel Pettigrew, President of the Executive Board and Chief Operating Officer, Ferring Pharmaceuticals. \u201cZomaJet addresses the common problem of needle fear in children, lowering the burden for patients and care givers and leading to better adherence to treatment.\u201d<\/p>\n<p>Ferring is a recognised speciality player in endocrinology, with a commitment to addressing the unmet medical needs of patients with childhood growth disorders including GHD and Turner Syndrome.<\/p>\n<p>– ENDS –<\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 style=\"color: #0088ce\">About ZomaJet\u2122<\/h3>\n<p>ZomaJet devices are needle-free delivery systems for the administration of Zomacton\u00ae (somatropin) human growth hormone (hGH).<\/p>\n<h3 style=\"color: #0088ce\">About Zomacton<sup>\u00ae<\/sup><\/h3>\n<p>Zomacton<strong><sup>\u00ae<\/sup><\/strong>\u00a0(somatropin) is a synthetic human growth hormone (hGH) produced by recombinant DNA technology. The main use for the product is to treat Growth Hormone Deficiency (GHD) in children and Turner Syndrome in girls.<\/p>\n<h3 style=\"color: #0088ce\">About Ferring Pharmaceuticals<\/h3>\n<p>Headquartered in Saint-Prex, Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. A leader in reproductive and maternal health, Ferring has been developing treatments for mothers and babies for over 50 years. Today, over one third of the company\u2019s research and development investment goes towards finding innovative treatments to help mothers and babies, from conception to birth. The company also identifies, develops and markets innovative products in the areas of urology, gastroenterology, endocrinology and orthopaedics. Ferring has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.<\/p>\n<p>For further information on Ferring or its products, visit <a href=\"https:\/\/www.ferring.com\/\">www.ferring.com<\/a>.<\/p>\n<p>Ferring is on Twitter. Follow us @FerringNews at <a href=\"http:\/\/twitter.com\/FerringNews\">http:\/\/twitter.com\/FerringNews<\/a><\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 style=\"color: #0088ce\">For more information, please contact<\/h3>\n<p><strong>Lindsey Rodger<br \/>\n<\/strong><em>Senior Manager, Corporate Communications<\/em><br \/>\n+41 58 451 4023 (direct)<br \/>\n+41 79 191 0486 (mobile)<br \/>\n<a href=\"mailto:lindsey.rodger@ferring.com\">lindsey.rodger@ferring.com<\/a><\/p>\n<p><strong>Bhavin Vaid<\/strong><br \/>\n<em>Head of Corporate Communications<\/em><br \/>\n+41 58 301 0952 (direct)<br \/>\n+41 79 191 0632 (mobile)<br \/>\n<a href=\"mailto:bhavin.vaid@ferring.com\">bhavin.vaid@ferring.com<\/a><\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”]\n<h3 style=\"color: #0088ce\">References<\/h3>\n<ol>\n<li id=\"note1\">Haverkamp F. & Gasteyger G. Journal of Medical Economics 2011; 14(4): 448-457<\/li>\n<li id=\"note2\">Wickramasuriya B.P.\u00a0<em>et al<\/em>, Horm Res 2006; 65(1): 18-22<\/li>\n<li id=\"note3\">Main K.M.\u00a0<em>et al<\/em>, Acta Paediatr 1995; 84(3): 331-334<\/li>\n<\/ol>\n[\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_row element_name=”Row” wrap_type=”content-width” parallax_image_height=”content-height” parallax_image_movement=”fixed” parallax_image_speed=”0.5″ bg_video_loop=”yes” parallax_video_height=”window-height” parallax_video_overlay=”none” row_overlay_opacity=”0″ row_col_pos=”default” minimize_row=”no” width=”1\/1″ el_position=”first last”] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_button button_text=”READ MORE PRESS RELEASES” button_size=”standard” button_colour=”accent” button_type=”standard” rounded=”no” button_dropshadow=”no” button_link=”\/media\/press-releases\/” button_target=”_self” align=”center” animation=”none” animation_delay=”0″ width=”1\/1″ el_position=”first last”] [\/spb_row]\n","protected":false},"excerpt":{"rendered":"<p>[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring enters agreement with Antares Pharma Inc. for worldwide rights to ZomaJet\u2122 needle-free injector device ZomaJet is used to deliver Ferring\u2019s Zomacton\u00ae\u00a0(somatropin), indicated to treat […]<\/p>\n","protected":false},"author":2410,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[244],"tags":[],"class_list":["post-22803","post","type-post","status-publish","format-standard","hentry","category-press-release-2017"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.3 (Yoast SEO v23.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device - Ferring Global<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device\" \/>\n<meta property=\"og:description\" content=\"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring enters agreement with Antares Pharma Inc. for worldwide rights to ZomaJet\u2122 needle-free injector device ZomaJet is used to deliver Ferring\u2019s Zomacton\u00ae\u00a0(somatropin), indicated to treat […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/\" \/>\n<meta property=\"og:site_name\" content=\"Ferring Global\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-10-10T09:54:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-10T17:06:26+00:00\" \/>\n<meta name=\"author\" content=\"pulse\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ferring\" \/>\n<meta name=\"twitter:site\" content=\"@ferring\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"pulse\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/\"},\"author\":{\"name\":\"pulse\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d\"},\"headline\":\"Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device\",\"datePublished\":\"2017-10-10T09:54:36+00:00\",\"dateModified\":\"2021-05-10T17:06:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/\"},\"wordCount\":805,\"publisher\":{\"@id\":\"https:\/\/www.ferring.com\/#organization\"},\"articleSection\":[\"PRESS RELEASE 2017\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/\",\"url\":\"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/\",\"name\":\"Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device - Ferring Global\",\"isPartOf\":{\"@id\":\"https:\/\/www.ferring.com\/#website\"},\"datePublished\":\"2017-10-10T09:54:36+00:00\",\"dateModified\":\"2021-05-10T17:06:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ferring.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ferring.com\/#website\",\"url\":\"https:\/\/www.ferring.com\/\",\"name\":\"Ferring Pharmaceuticals\",\"description\":\"Helping people live better lives\",\"publisher\":{\"@id\":\"https:\/\/www.ferring.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ferring.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ferring.com\/#organization\",\"name\":\"Ferring\",\"url\":\"https:\/\/www.ferring.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png\",\"contentUrl\":\"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png\",\"width\":236,\"height\":154,\"caption\":\"Ferring\"},\"image\":{\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\",\"https:\/\/x.com\/ferring\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d\",\"name\":\"pulse\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g\",\"caption\":\"pulse\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device - Ferring Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/","og_locale":"en_US","og_type":"article","og_title":"Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device","og_description":"[spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device [\/spb_boxed_content] [spb_blank_spacer height=”30px” width=”1\/1″ el_position=”first last”] [spb_boxed_content type=”coloured” box_link_target=”_self” padding_vertical=”0″ padding_horizontal=”0″ width=”1\/1″ el_position=”first last”] Ferring enters agreement with Antares Pharma Inc. for worldwide rights to ZomaJet\u2122 needle-free injector device ZomaJet is used to deliver Ferring\u2019s Zomacton\u00ae\u00a0(somatropin), indicated to treat […]","og_url":"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/","og_site_name":"Ferring Global","article_publisher":"https:\/\/www.facebook.com\/ferringpharmaceuticals\/","article_published_time":"2017-10-10T09:54:36+00:00","article_modified_time":"2021-05-10T17:06:26+00:00","author":"pulse","twitter_card":"summary_large_image","twitter_creator":"@ferring","twitter_site":"@ferring","twitter_misc":{"Written by":"pulse","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/#article","isPartOf":{"@id":"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/"},"author":{"name":"pulse","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d"},"headline":"Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device","datePublished":"2017-10-10T09:54:36+00:00","dateModified":"2021-05-10T17:06:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/"},"wordCount":805,"publisher":{"@id":"https:\/\/www.ferring.com\/#organization"},"articleSection":["PRESS RELEASE 2017"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/","url":"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/","name":"Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device - Ferring Global","isPartOf":{"@id":"https:\/\/www.ferring.com\/#website"},"datePublished":"2017-10-10T09:54:36+00:00","dateModified":"2021-05-10T17:06:26+00:00","breadcrumb":{"@id":"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ferring.com\/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ferring.com\/"},{"@type":"ListItem","position":2,"name":"Ferring strengthens growth hormone franchise Zomacton\u00ae through acquisition of ZomaJet\u2122 needle-free injector device"}]},{"@type":"WebSite","@id":"https:\/\/www.ferring.com\/#website","url":"https:\/\/www.ferring.com\/","name":"Ferring Pharmaceuticals","description":"Helping people live better lives","publisher":{"@id":"https:\/\/www.ferring.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ferring.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ferring.com\/#organization","name":"Ferring","url":"https:\/\/www.ferring.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/","url":"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png","contentUrl":"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png","width":236,"height":154,"caption":"Ferring"},"image":{"@id":"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ferringpharmaceuticals\/","https:\/\/x.com\/ferring"]},{"@type":"Person","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d","name":"pulse","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g","caption":"pulse"}}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/22803"}],"collection":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/users\/2410"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/comments?post=22803"}],"version-history":[{"count":0,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/22803\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/media?parent=22803"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/categories?post=22803"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/tags?post=22803"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}